Conversion and pharmacokinetics profiles of a novel pro-drug of 3-n-butylphthalide, potassium 2-(1-hydroxypentyl)-benzoate, in rats and dogs

Potassium 2-(1-hydroxypentyl)-benzoate (d/-PHPB) is a novel pro-drug of 3-n-butylphthalide (dkNBP) that is used to treat ischemic stroke. Currently, dl-PHPB is in phase II-III clinical trials in China. In this study, we investigated the conversion and pharmacokinetics profiles of dI-PHPB in vitro an...

Full description

Saved in:
Bibliographic Details
Published in中国药理学报:英文版 Vol. 39; no. 2; pp. 275 - 285
Main Author Jiang LI;Shao-feng XU;Ying PENG;Nan FENG;Ling WANG;Xiao-liang WANG
Format Journal Article
LanguageEnglish
Published 2018
Subjects
Online AccessGet full text

Cover

Loading…